A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors
Clinical trial NCT01413503 · COMPLETED
Trial details
- NCT number
- NCT01413503
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1991-05-01
- Primary completion
- 2007-09-06
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.